COMMUNIQUÉS West-GlobeNewswire

Anosh Inc. Foundation Reflects on a Year of Transformative Impact in 2023
16/07/2024
Anosh Inc. Foundation marks a year of pivotal support and charity, uplifting communities through significant donations and active involvement CHICAGO, July 16, 2024 (GLOBE NEWSWIRE) -- As we reach the midpoint of 2024, [...]
Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer
16/07/2024
Accomplished cultural transformation leader brings extensive company-building expertise CAMBRIDGE, Mass, July 16, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced that Tamara Dillon has joined the [...]
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
16/07/2024
Investigational New Drug (IND) application to be filed in the fourth quarter of 2024 Phase 1 clinical trial in children with DIPG to be initiated in early 2025 RALEIGH, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- FLAG [...]
RosenCare and PeopleOne Health Join Forces to Transform Healthcare Market in Florida
16/07/2024
New partnership aims to deliver exceptional primary care to millions of people in the region PITTSBURGH and ORLANDO, Fla., July 16, 2024 (GLOBE NEWSWIRE) -- RosenCare , a premier healthcare provider known for its [...]
The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello
16/07/2024
STUDIO CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members, Myeloma Support Group Leader Jack [...]
Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
16/07/2024
LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and [...]
Senti Bio Announces Reverse Stock Split
16/07/2024
Shares expected to begin trading on split-adjusted basis on July 18, 2024 SOUTH SAN FRANCISCO, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”) , a biotechnology company [...]
CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial
16/07/2024
Reimbursement expected to accelerate medical site activations and cover a portion of the Company’s NEUTRALIZE-AKI trial costs DENVER, July 16, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), [...]
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada
16/07/2024
July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical [...]
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024
Second-Quarter and First-Half 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024
Second-Quarter and First-Half 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Panthera BioSolutions Launches Pharmaceutical Good Manufacturing Practice (GMP) Foundational Training Course with Dallas College to Advance Workforce Talent Pipeline in North Texas
15/07/2024
DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is proud to announce a strategic partnership between Dallas College and Panthera BioSolutions, a [...]
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine
15/07/2024
Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month. WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) -- Sabin Vaccine Institute launched a [...]
SoldierStrong Marks 15ᵗʰ Anniversary With Focus on New Approaches to Help Veterans Take Their Next Steps Forward
15/07/2024
STAMFORD, Conn., July 15, 2024 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit group committed to donating revolutionary medical technology to improve the lives of injured veterans, marks its 15 th anniversary today with [...]
Third Year in a Row, LifeLabs Named by Forbes as one of Canada's Best Employers for Diversity
15/07/2024
Toronto, July 15, 2024 (GLOBE NEWSWIRE) -- LifeLabs has once again been named one of Canada's Best Employers for Diversity by Forbes. This is the third consecutive year LifeLabs has received this recognition. Forbes and [...]
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
15/07/2024
HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]
IR-MED Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers
15/07/2024
DiaSafe ™ , IR-MED’s second product , is being developed to provide safe, real-time optical readings of biomarkers to detect the early presence of diabetic foot ulcers with high accuracy Th e most common cause of [...]
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series
15/07/2024
Live video webcast on Wednesday, July 17 th at 12:00 PM ET LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an [...]
SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
15/07/2024
Five total abstracts presented at ASPN 2024 CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics’ SPRINT PNS System generated interest from leading pain physicians at the American [...]

Pages